Flexeril and Drug tolerance decreased - a phase IV clinical study of FDA data
Drug tolerance decreased is reported only by a few people who take Flexeril.
The phase IV clinical study analyzes which people take Flexeril and have Drug tolerance decreased. It is created by eHealthMe based on reports of 33,460 people who have side effects while taking Flexeril from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
33,460 people reported to have side effects when taking Flexeril.
Among them, 2 people (0.01%) have Drug tolerance decreased.
What is Flexeril?
Flexeril has active ingredients of cyclobenzaprine hydrochloride. It is often used in muscle spasms. eHealthMe is studying from 35,864 Flexeril users for its effectiveness, alternative drugs and more.
What is Drug tolerance decreased?
Drug tolerance decreased is found to be associated with 527 drugs and 310 conditions by eHealthMe.
Number of Flexeril and Drug tolerance decreased reports submitted per year:
Gender of people who have Drug tolerance decreased when taking Flexeril *:
- female: 50 %
- male: 50 %
Age of people who have Drug tolerance decreased when taking Flexeril *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 100 %
- 50-59: 0.0 %
- 60+: 0.0 %
Common drugs people take besides Flexeril *:
- Zemplar: 1 person, 50.00%
- Zebeta: 1 person, 50.00%
- Zaroxolyn: 1 person, 50.00%
- Vioxx: 1 person, 50.00%
- Viagra: 1 person, 50.00%
- Ultralente Insulin: 1 person, 50.00%
- Toprol-Xl: 1 person, 50.00%
- Skelaxin: 1 person, 50.00%
- Sandimmune: 1 person, 50.00%
- Norvasc: 1 person, 50.00%
Common side effects people have besides Drug tolerance decreased *:
- Weight Decreased: 1 person, 50.00%
- Injury: 1 person, 50.00%
- Aortic Valve Incompetence: 1 person, 50.00%
- Atherosclerosis (disorder of the arteries): 1 person, 50.00%
- Cardiac Failure Congestive: 1 person, 50.00%
- Congestive Cardiac Failure Aggravated (worse dilated impaired heart function): 1 person, 50.00%
- Congestive Cardiomyopathy (weakening of heart muscle): 1 person, 50.00%
- Drug Hypersensitivity: 1 person, 50.00%
- Drug Ineffective: 1 person, 50.00%
- Electrocardiogram Q Wave Abnormal: 1 person, 50.00%
Common conditions people have *:
- Pain: 1 person, 50.00%
- High Blood Cholesterol: 1 person, 50.00%
* Approximation only. Some reports may have incomplete information.
Do you take Flexeril and have Drug tolerance decreased?Check whether Drug tolerance decreased is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Drug tolerance decreased and when was it recovered:
Expand to all the drugs that have ingredients of cyclobenzaprine hydrochloride:
Alternative drugs to, pros and cons of Flexeril:
- Flexeril (35,864 reports)
Common Flexeril side effects:
Browse all side effects of Flexeril:a b c d e f g h i j k l m n o p q r s t u v w x y z
Drug tolerance decreased treatments and more:
- Drug tolerance decreased (2,209 reports)
COVID vaccines that are related to Drug tolerance decreased:
- Drug tolerance decreased in Moderna COVID Vaccine
- Drug tolerance decreased in Pfizer BioNTech Covid Vaccine
- Drug tolerance decreased in Johnson and Johnson Covid Vaccine
Common drugs associated with Drug tolerance decreased:
All the drugs that are associated with Drug tolerance decreased:
- Drug tolerance decreased (527 drugs)
Common conditions associated with Drug tolerance decreased:
All the conditions that are associated with Drug tolerance decreased:
- Drug tolerance decreased (310 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on cyclobenzaprine hydrochloride (the active ingredients of Flexeril) and Flexeril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Xanax and Tooth Fracture - 7 seconds ago
- Diazepam and Dupuytren'S Contracture - 9 seconds ago
- Tofranil and Weils Disease - 11 seconds ago
- Xeljanz Xr and Erythema Multiforme - 24 seconds ago
- Nplate and Spinal Pain - 26 seconds ago
- Seroquel and Renal Mass - 26 seconds ago
- Stress And Anxiety and Tricuspid Valve Disease - 33 seconds ago
- Percocet and Psoriatic Arthropathy - 41 seconds ago
- Dexamethasone and Hypoxic-Ischaemic Encephalopathy - 51 seconds ago
- Temozolomide and Diabetes Insipidus - Nephrogenic - 53 seconds ago